1504 related articles for article (PubMed ID: 28324674)
1. Osteoblast-osteoclast interactions.
Chen X; Wang Z; Duan N; Zhu G; Schwarz EM; Xie C
Connect Tissue Res; 2018 Mar; 59(2):99-107. PubMed ID: 28324674
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-Osteoclast Communication and Bone Homeostasis.
Kim JM; Lin C; Stavre Z; Greenblatt MB; Shim JH
Cells; 2020 Sep; 9(9):. PubMed ID: 32927921
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast and osteoclast crosstalks: from OAF to Ephrin.
Tamma R; Zallone A
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):196-200. PubMed ID: 22280242
[TBL] [Abstract][Full Text] [Related]
4. Low levels of cadmium exposure affect bone by inhibiting Lgr4 expression in osteoblasts and osteoclasts.
Wang M; Liu J; Zhu G; Chen X
J Trace Elem Med Biol; 2022 Sep; 73():127025. PubMed ID: 35772369
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A
Mediero A; Wilder T; Shah L; Cronstein BN
FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
[TBL] [Abstract][Full Text] [Related]
7. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
[TBL] [Abstract][Full Text] [Related]
10. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
[TBL] [Abstract][Full Text] [Related]
11. Boning up on ephrin signaling.
Mundy GR; Elefteriou F
Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
14. Molecular signaling in bone cells: Regulation of cell differentiation and survival.
Plotkin LI; Bruzzaniti A
Adv Protein Chem Struct Biol; 2019; 116():237-281. PubMed ID: 31036293
[TBL] [Abstract][Full Text] [Related]
15. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
17. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
[TBL] [Abstract][Full Text] [Related]
19. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
20. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
